Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

UNIMED ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   2.3% 2.3% 2.3% 2.3% 2.3% 2.3% 2.3% 2.3%   Bankruptcy risk   3.8% 5.3% 18.9% 11.7% 7.2% 4.6% 17.8% 17.5%   Credit score (0-100)   52 43 7 19 33 45 8 9   Credit rating   BBB BBB B BB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 -0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,065 289 170 542 2,678 1,533 0.0 0.0   EBITDA   387 -251 -307 81.2 1,878 733 0.0 0.0   EBIT   261 -377 -433 -13.0 1,878 733 0.0 0.0   Pre-tax profit (PTP)   260.5 -377.2 -433.3 -13.5 1,880.3 638.2 0.0 0.0   Net earnings   203.2 -296.5 -361.6 -10.5 1,466.7 498.1 0.0 0.0   Pre-tax profit without non-rec. items   261 -377 -433 -13.5 1,880 638 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   345 220 94.2 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   520 223 -138 -149 1,318 816 15.9 15.9   Interest-bearing liabilities   609 571 656 450 1,179 94.6 0.0 0.0   Balance sheet total (assets)   1,313 851 678 448 2,972 1,324 15.9 15.9   Net Debt   37.4 384 582 339 -1,534 -413 -15.9 -15.9     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,065 289 170 542 2,678 1,533 0.0 0.0   Gross profit growth   63.6% -72.9% -41.3% 219.7% 393.7% -42.8% -100.0% 0.0%   Employees   2 2 2 2 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -50.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,313 851 678 448 2,972 1,324 16 16   Balance sheet change%   2.1% -35.2% -20.3% -33.9% 563.4% -55.4% -98.8% 0.0%   Added value   386.6 -251.4 -307.1 81.2 1,972.6 732.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -251 -251 -251 -188 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 -2.0 -3.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   24.5% -130.4% -255.0% -2.4% 70.1% 47.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   20.1% -34.9% -51.9% -1.8% 105.4% 38.5% 0.0% 0.0%   ROI %   24.8% -38.8% -59.5% -2.4% 127.7% 37.5% 0.0% 0.0%   ROE %   48.6% -79.8% -80.2% -1.9% 166.1% 46.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   39.6% 26.2% -17.0% -25.0% 44.3% 61.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   9.7% -152.7% -189.7% 417.3% -81.7% -56.4% 0.0% 0.0%   Gearing %   117.1% 255.7% -473.8% -302.5% 89.4% 11.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.1% 0.0% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   1.2 0.9 0.6 0.6 2.3 3.8 0.0 0.0   Current Ratio   1.2 0.9 0.6 0.6 2.3 3.8 0.0 0.0   Cash and cash equivalent   571.3 186.8 73.3 111.6 2,712.6 507.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   162.9 -86.6 -327.2 -240.5 1,612.2 976.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   193 -126 -154 41 1,973 733 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   193 -126 -154 41 1,878 733 0 0   EBIT / employee   131 -189 -216 -7 1,878 733 0 0   Net earnings / employee   102 -148 -181 -5 1,467 498 0 0